Autopsy report · NCT02404363

Safety and Efficacy of Clopidogrel in Locally Advanced and Metastatic Pancreatic Adenocarcinoma Treated With Chemotherapy

“recruitment problem”

The sponsor’s own words in the registry.

Life of this trial

• Registered 10 months before it started.
• Ran for about 2 years 3 months before it stopped.
• 39 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Assistance Publique - Hôpitaux de Paris

Sponsor type

University, hospital or other

Conditions

Locally Advanced Pancreatic Cancer; Adenocarcinoma, Pancreas; Metastatic Pancreatic Cancer

Interventions

Clopidogrel; Placebo

Participants

39

Sites

1

Countries

France

Trials that died the same way

• Progesterone vs Clobetasol Propionate in Vulvar Lichen Sclerosus
  “Recruitment problems” (95% match in meaning)
• Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer
  “Problems of recruitment” (91% match in meaning)
• Burden of Obstructive Sleep Apnea in Stroke (BOSAST)
  “problems with recruitment” (90% match in meaning)
• The Occlusive Dressing
  “recruitment difficulty” (89% match in meaning)
• ACTHAR Therapy for Central Nervous System Sarcoidosis
  “Difficulty with recruitment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.